These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 1382289)

  • 21. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet cell antibodies: variable immunostaining of pancreatic islet cells and carcinoid tissue.
    Hallberg A; Juhlin C; Berne C; Kämpe O; Karlsson FA
    J Intern Med; 1995 Sep; 238(3):207-13. PubMed ID: 7673849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for somatic mutation and affinity maturation of diabetes associated human autoantibodies to glutamate decarboxylase.
    Jury KM; Loeffler D; Eiermann TH; Ziegler B; Boehm BO; Richter W
    J Autoimmun; 1996 Jun; 9(3):371-7. PubMed ID: 8816973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I; Hummel M; Ziegler AG
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus.
    Richter WO; Donner MG; Schwandt P
    J Clin Apher; 1997; 12(4):196-9. PubMed ID: 9483183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I; Souchier C; Thivolet C
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
    Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
    Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
    De Aizpurua HJ; Wilson YM; Harrison LC
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
    Lan MS; Wasserfall C; Maclaren NK; Notkins AL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
    Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
    J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody.
    Pak CY; Cha CY; Rajotte RV; McArthur RG; Yoon JW
    Diabetologia; 1990 Sep; 33(9):569-72. PubMed ID: 2174808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical differentiation of monoclonal GAD antibodies recognizing linear or conformational epitope regions.
    Augstein P; Ziegler B; Schlosser M; Flassig S; Strebelow M; Ziegler M
    Pancreas; 1997 Aug; 15(2):139-46. PubMed ID: 9260198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies.
    Richter W; Mertens T; Schoel B; Muir P; Ritzkowsky A; Scherbaum WA; Boehm BO
    J Exp Med; 1994 Aug; 180(2):721-6. PubMed ID: 7913951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
    Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
    Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR
    Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.